Titles: H.R.2375 — 116th Congress (2019-2020)All Information (Except Text)

Short Titles

Short Titles - House of Representatives

Short Title(s) as Reported to House

Preserve Access to Affordable Generics and Biosimilars Act

Short Title(s) as Introduced

Preserve Access to Affordable Generics and Biosimilars Act

Official Titles

Official Titles - House of Representatives

Official Title as Introduced

To prohibit prescription drug companies from compensating other prescription drug companies to delay the entry of a generic drug, biosimilar biological product, or interchangeable biological product into the market.